HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Doxepin inhibits GPVI-dependent platelet Ca2+ signaling and collagen-dependent thrombus formation.

Abstract
Platelet adhesion, activation, and aggregation are essential for primary hemostasis, but are also critically involved in the development of acute arterial thrombotic occlusion. Stimulation of the collagen receptor glycoprotein VI (GPVI) leads to phospholipase Cγ2-dependent inositol triphosphate (IP3) production with subsequent platelet activation, due to increased intracellular Ca2+ concentration ([Ca2+]i). Although tricyclic antidepressants have been shown to potentially impair platelet activation, nothing is hitherto known about potential effects of the tricyclic antidepressant doxepin on platelet Ca2+ signaling and thrombus formation. As shown in the present study, doxepin significantly diminished the stimulatory effect of GPVI agonist collagen-related peptide (CRP) on intracellular Ca2+ release as well as subsequent extracellular Ca2+ influx. Doxepin was partially effective by impairment of CRP-dependent IP3 production. Moreover, doxepin abrogated CRP-induced platelet degranulation and integrin αIIbβ3 activation and aggregation. Finally, doxepin markedly blunted in vitro platelet adhesion to collagen and thrombus formation under high arterial shear rates (1,700-s). In conclusion, doxepin is a powerful inhibitor of GPVI-dependent platelet Ca2+ signaling, platelet activation, and thrombus formation.
AuthorsSascha Geue, Britta Walker-Allgaier, Daniela Eißler, Roland Tegtmeyer, Malte Schaub, Florian Lang, Meinrad Gawaz, Oliver Borst, Patrick Münzer
JournalAmerican journal of physiology. Cell physiology (Am J Physiol Cell Physiol) Vol. 312 Issue 6 Pg. C765-C774 (Jun 01 2017) ISSN: 1522-1563 [Electronic] United States
PMID28404545 (Publication Type: Journal Article)
CopyrightCopyright © 2017 the American Physiological Society.
Chemical References
  • Antidepressive Agents, Tricyclic
  • Carrier Proteins
  • Peptides
  • Platelet Aggregation Inhibitors
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • Platelet Membrane Glycoproteins
  • collagen-related peptide
  • platelet membrane glycoprotein VI
  • Doxepin
  • Inositol 1,4,5-Trisphosphate
  • Phospholipase C gamma
  • Calcium
Topics
  • Animals
  • Antidepressive Agents, Tricyclic (pharmacology)
  • Blood Platelets (cytology, drug effects, metabolism)
  • Calcium (metabolism)
  • Calcium Signaling (drug effects)
  • Carrier Proteins (antagonists & inhibitors, genetics, metabolism)
  • Cell Degranulation (drug effects)
  • Cells, Cultured
  • Doxepin (pharmacology)
  • Female
  • Gene Expression Regulation
  • Inositol 1,4,5-Trisphosphate (metabolism)
  • Ion Transport (drug effects)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Peptides (antagonists & inhibitors, genetics, metabolism)
  • Phospholipase C gamma (genetics, metabolism)
  • Platelet Activation (drug effects)
  • Platelet Adhesiveness (drug effects)
  • Platelet Aggregation (drug effects)
  • Platelet Aggregation Inhibitors (pharmacology)
  • Platelet Glycoprotein GPIIb-IIIa Complex (genetics, metabolism)
  • Platelet Membrane Glycoproteins (antagonists & inhibitors, genetics, metabolism)
  • Stress, Mechanical
  • Thrombosis (prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: